Wednesday, September 06, 2017 8:05:05 AM
CBIO - 3.39 Pre-market now at 3.80/3.90
BZ: Catalyst Biosciences Reports Factor IX Data: 'CB 2679d/ISU304 is approximately 22 times more potent than current hemophilia B therapy'
Catalyst Biosciences Announces Positive Factor IX Clinical Data
BZ: Catalyst Biosciences Reports Factor IX Data: 'CB 2679d/ISU304 is approximately 22 times more potent than current hemophilia B therapy'
Catalyst Biosciences Announces Positive Factor IX Clinical Data
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
